Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a software/platform update. No study details or page content appear to be affected.
    Difference
    0.1%
    Check dated 2026-08-29T23:38:59.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page shows an updated revision label from v3.6.4 to v3.6.5, indicating a small update to the page or its underlying system.
    Difference
    0.1%
    Check dated 2026-08-08T20:31:03.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3 revision tag to reflect a newer version label.
    Difference
    0.1%
    Check dated 2026-07-25T12:58:44.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated from v3.6.2 to v3.6.3, indicating a minor version update to the page. This change does not modify visible content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-07-04T04:12:23.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's version. No changes to the study details are reflected in this update.
    Difference
    0.1%
    Check dated 2026-06-27T01:50:55.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    No longer looking for participants is now shown on the page, indicating the study has closed enrollment. This update communicates that eligibility and enrollment are no longer active for this trial.
    Difference
    0.4%
    Check dated 2026-06-12T16:46:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.